Exenatide (Byetta) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans.
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2012
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 21 Jun 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jun 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 03 Feb 2010 New trial record